Editas Medicine to Present at Upcoming February Investor Conferences

CAMBRIDGE, Mass., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that management will present a company overview at two upcoming investor conferences in February.  Details of the presentations are as follows:

Live webcasts of the presentations will be available on the Investors & Media section of the Editas website at www.editasmedicine.com.  Archived replays will be available for approximately 30 days following the respective presentations.

About Editas MedicineEditas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.  The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Dan Budwick

Pure Communications, Inc.

(973) 271-6085
[email protected]

Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083
[email protected]

You May Also Be Interested In

• Editas Medicine to Participate in Upcoming Investor Conferences
• ProMedia Training Becomes First U.S. Professional Training Partner to Offer Official Solid State Logic (SSL) Certified Training for Modern DAW Mixing Workflows
• Binance Listing News Meets Remittix’s $32M Date-Reveal Trigger as the SEC Publishes Its New Crypto Rulebook